FDA Inspection 1320234 — Marjo S. van der Knaap, MD, PhD

Marjo S. van der Knaap, MD, PhD — FEI 3043320973

The FDA completed an inspection of Marjo S. van der Knaap, MD, PhD on May 15, 2026 in Amsterdam. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 15, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Amsterdam (Netherlands)

Additional Details

Clinical Investigator (CI)